Head & Neck Cancer

Latest News

Phase 2 data also highlight an improvement in disease control rate with setanaxib/pembrolizumab in squamous cell carcinoma of the head and neck.
Setanaxib/Pembrolizumab Improves Survival in Head and Neck Cancer

May 8th 2024

Phase 2 data also highlight an improvement in disease control rate with setanaxib/pembrolizumab in squamous cell carcinoma of the head and neck.

Head and neck cancer
Early Intervention, Regular Assessment Can Grasp Symptom Course for Head and Neck Cancer Therapy

April 28th 2024

FDA Gives Fast Track Designation to LYT-200 in Advanced Head and Neck Cancers
FDA Gives Fast Track Designation to LYT-200 in Advanced Head and Neck Cancers

April 12th 2024

Prognostic Factors Linked With Poor Locoregional Control in Tongue Cancer | Image Credit: © freshidea - stock.adobe.com.
Prognostic Factors Linked With Poor Locoregional Control in Tongue Cancer

March 5th 2024

 Radiation Therapy Plus Chemo Yielded Increased Efficacy in HPV+ Oropharynx Cancer
Radiation Therapy Plus Chemo Yielded Increased Efficacy in HPV+ Oropharynx Cancer

March 4th 2024